天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

2-bromo-N-(5-{[2-(dibenzo[b,d]furan-3-ylamino)-2-oxoethyl]sulfanyl}-1,3,4-thiadiazol-2-yl)benzamide

CAS No.
532980-33-9
Chemical Name:
2-bromo-N-(5-{[2-(dibenzo[b,d]furan-3-ylamino)-2-oxoethyl]sulfanyl}-1,3,4-thiadiazol-2-yl)benzamide
Synonyms
Benzamide, 2-bromo-N-[5-[[2-(3-dibenzofuranylamino)-2-oxoethyl]thio]-1,3,4-thiadiazol-2-yl]-;2-bromo-N-(5-{[2-(dibenzo[b,d]furan-3-ylamino)-2-oxoethyl]sulfanyl}-1,3,4-thiadiazol-2-yl)benzamide
CBNumber:
CB32041262
Molecular Formula:
C23H15BrN4O3S2
Molecular Weight:
539.42
MDL Number:
MOL File:
532980-33-9.mol

2-bromo-N-(5-{[2-(dibenzo[b,d]furan-3-ylamino)-2-oxoethyl]sulfanyl}-1,3,4-thiadiazol-2-yl)benzamide Properties

Density 1.69±0.1 g/cm3(Predicted)
pka 6.84±0.50(Predicted)

2-bromo-N-(5-{[2-(dibenzo[b,d]furan-3-ylamino)-2-oxoethyl]sulfanyl}-1,3,4-thiadiazol-2-yl)benzamide Preparation Products And Raw materials

Raw materials

Preparation Products

2-bromo-N-(5-{[2-(dibenzo[b,d]furan-3-ylamino)-2-oxoethyl]sulfanyl}-1,3,4-thiadiazol-2-yl)benzamide Suppliers

Global( 3)Suppliers
Supplier Tel Email Country ProdList Advantage
PHARMEKS Ltd. -- sales@pharmeks.com Finland 6349 50
Interbioscreen Ltd. -- screen@ibscreen.chg.ru Finland 6176 60
Specs -- info@specs.net The Netherlands 6833 70
Supplier Advantage
PHARMEKS Ltd. 50
Interbioscreen Ltd. 60
Specs 70
2-bromo-N-(5-{[2-(dibenzo[b,d]furan-3-ylamino)-2-oxoethyl]sulfanyl}-1,3,4-thiadiazol-2-yl)benzamide Benzamide, 2-bromo-N-[5-[[2-(3-dibenzofuranylamino)-2-oxoethyl]thio]-1,3,4-thiadiazol-2-yl]- 532980-33-9 C23H15BrN4O3S2
This site uses cookies
This website uses cookies and similar technologies to store and retrieve information about your use of this website. This information helps us to provide, analyse and improve our services, which may include personalised content or advertising. We may share this information with Google and other third parties. This cookies are necessary for our website to work properly . By clicking "Continue" or continuing to browse our site you are agreeing to our and our partners use of cookies.
Accept